Actieve functies van David S. Johnson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
GigaGen, Inc.
 GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | 01-01-2010 | - | |
| Oprichter | 01-01-2010 | - | |
| President | 01-01-2010 | - | |
GigaMune, Inc.
 GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Algemeen Directeur | - | - |
| Financieel Directeur/CFO | - | - | |
| Bedrijfssecretaris | - | - |
Loopbaan van David S. Johnson
Eerdere bekende functies van David S. Johnson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NATERA, INC. | Operationeel Directeur | - | - |
| Stanford University | Corporate Officer/Principal | - | - |
Opleiding van David S. Johnson
| Stanford University | Doctorate Degree |
| Duke University | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Health Technology |
GigaMune, Inc.
GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Health Technology |
- Beurs
- Insiders
- David S. Johnson
- Ervaring
